留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

灯盏花乙素抗氧化应激机制在防治心脑血管疾病中的研究进展

董丽 孙士波 孙曙光

董丽, 孙士波, 孙曙光. 灯盏花乙素抗氧化应激机制在防治心脑血管疾病中的研究进展[J]. 昆明医科大学学报, 2022, 43(4): 146-151. doi: 10.12259/j.issn.2095-610X.S20220423
引用本文: 董丽, 孙士波, 孙曙光. 灯盏花乙素抗氧化应激机制在防治心脑血管疾病中的研究进展[J]. 昆明医科大学学报, 2022, 43(4): 146-151. doi: 10.12259/j.issn.2095-610X.S20220423
Li DONG, Shibo SUN, Shuguang SUN. Advances on Scutellarin Anti-Oxidative Stress Mechanism in the Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases[J]. Journal of Kunming Medical University, 2022, 43(4): 146-151. doi: 10.12259/j.issn.2095-610X.S20220423
Citation: Li DONG, Shibo SUN, Shuguang SUN. Advances on Scutellarin Anti-Oxidative Stress Mechanism in the Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases[J]. Journal of Kunming Medical University, 2022, 43(4): 146-151. doi: 10.12259/j.issn.2095-610X.S20220423

灯盏花乙素抗氧化应激机制在防治心脑血管疾病中的研究进展

doi: 10.12259/j.issn.2095-610X.S20220423
基金项目: 国家自然科学基金资助项目(82160007);云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目[2019FE001(-058)];云南省科技厅地方高校联合专项基金资助项目(202001BA070001-016)
详细信息
    作者简介:

    董丽(1993~),女,景颇族,云南陇川人,在读硕士研究生,主治医师,主要从事全科医学的临床研究工作

    通讯作者:

    孙曙光,E-mail:sshuglily@163.com

  • 中图分类号: R285

Advances on Scutellarin Anti-Oxidative Stress Mechanism in the Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases

  • 摘要: 灯盏花乙素,化学名为4,5,6-三羟基黄酮-7-葡糖苷酸,是中国传统中药灯盏花的主要活性成分。临床上,因其具有极其广泛的生物活性而被用于治疗心脑血管疾病。近年来,以高发病率、高死亡率为特点的心脑血管疾病已经成为中老年人的常见多发病,并随着人们饮食结构的转变,不良生活习惯的养成使该病的发病有了年轻化的趋势。氧化应激是心脑血管疾病发生、发展中极其重要的因素。而灯盏花乙素对心脑血管疾病的治疗有较好疗效,不难发现,灯盏花乙素对氧化应激有一定的抑制作用。旨在对灯盏花乙素与氧化应激的作用机制进行综述,并探讨灯盏花乙素对氧化应激抑制作用在临床上的应用,从而为今后临床疾病的治疗提供一定的参考。
  • [1] 刘杨,张方博,孙慧峰. 灯盏细辛治疗心脑血管疾病的药理与临床[J]. 中医学报,2020,35(12):2580-2583.
    [2] 范娅丹,韩江全. 灯盏花乙素的药理作用及临床应用进展[J]. 海南医学,2017,28(4):627-629. doi: 10.3969/j.issn.1003-6350.2017.04.036
    [3] 韩香,李惠惠,顾军. 灯盏乙素全合成及结构修饰研究进展[J]. 武警后勤学院学报(医学版),2020,29(1):64-71.
    [4] Wang L,Ma Q. Clinical benefits and pharmacology of scutellarin:A comprehensive review[J]. Pharmacol Ther,2018,190(10):105-127.
    [5] 刘靖丽,李娜,闫浩,等. 灯盏花乙素及其苷元结构与抗氧化活性关系研究[J]. 天然产物研究与开发,2018,30(8):1334-1339.
    [6] 唐春丽,魏江存,滕红丽,等. 黄酮类成分抗炎活性及其作用机制研究进展[J]. 中华中医药学刊,2021,39(4):154-159.
    [7] Liu Q,Li X,Ouyang X,et al. Dual effect of glucuronidation of a pyrogallol-type phytophenol antioxidant:A comparison between scutellarein and scutellarin[J]. Molecules,2018,23(12):3225. doi: 10.3390/molecules23123225
    [8] Hu X,Wu X,Zhao B,et al. Scutellarin protects human retinal pigment epithelial cells against hydrogen peroxide (H2O2)-induced oxidative damage[J]. Cell Biosci,2019,9(8):12.
    [9] 陈依林,李光才. 转录因子Nrf2在缺氧性肺血管重构中的作用机制[J]. 河北医药,2021,43(12):1783-1787. doi: 10.3969/j.issn.1002-7386.2021.12.005
    [10] Bellezza I,Giambanco I,Minelli A,et al. Nrf2-Keap1 signaling in oxidative and reductive stress[J]. Biochim Biophys Acta Mol Cell Res,2018,1865(5):721-733. doi: 10.1016/j.bbamcr.2018.02.010
    [11] Liu L,Locascio L M,Doré S. Critical role of nrf2 in experimental ischemic stroke[J]. Front Pharmacol,2019,10(3):153.
    [12] 徐成,陈朝红. 核因子E2相关因子2信号通路与肾脏疾病[J]. 肾脏病与透析肾移植杂志,2021,30(2):165-169. doi: 10.3969/j.issn.1006-298X.2021.02.014
    [13] Krajka Kuźniak V,Paluszczak J,Baer Dubowska W. The Nrf2-ARE signaling pathway:An update on its regulation and possible role in cancer prevention and treatment[J]. Pharmacol Rep,2017,69(3):393-402. doi: 10.1016/j.pharep.2016.12.011
    [14] 房娉平,阚敏宸,郭立静,等. 灯盏花素对血管性痴呆大鼠海马CA1区病理改变及Nrf2/HO-1通路的影响[J]. 中西医结合心脑血管病杂志,2021,19(16):2751-2756.
    [15] Wu H,Jia L. Scutellarin attenuates hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and oxidative stress through regulating Keap1/Nrf2/ARE signaling[J]. Biosci Rep,2019,39(11):20192501. doi: 10.1042/BSR20192501
    [16] 严晗. 野黄芩苷通过Nrf2/HO-1信号通路在db/db小鼠中降血糖及肾脏保护活性的研究[D]. 长春: 吉林大学硕士学位论文, 2020.
    [17] Xiao D,Zhou Q,Gao Y,et al. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade[J]. J Cell Biochem,2020,121(11):4542-4557. doi: 10.1002/jcb.29677
    [18] 谢延峥,马金,邹旭. PI3K/Akt信号通路串扰在心肌缺血再灌注损伤中的作用及中医药防治进展[J]. 中国实验方剂学杂志,2020,26(24):201-210.
    [19] Fan H,Ma X,Lin P,et al. Scutellarin prevents nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia via PI3K/AKT-dependent activation of nuclear factor (erythroid-derived 2)-Like 2 (Nrf2) in rats[J]. Med Sci Monit,2017,23(11):5599-5612.
    [20] Xu L J,Chen R C,Ma X Y,et al. Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation[J]. Phytomedicine,2020,68(2):153169.
    [21] Liu F,Zu X,Xie X,et al. Scutellarin suppresses patient-derived xenograft tumor growth by directly targeting AKT in esophageal squamous cell carcinoma[J]. Cancer Prev Res (Phila),2019,12(12):849-860. doi: 10.1158/1940-6207.CAPR-19-0244
    [22] 张赫,郑焱. β淀粉样蛋白级联假说相关的阿尔茨海默病发病机制及防治策略研究进展[J]. 中国医学科学院学报,2019,41(05):702-708.
    [23] Butterfield D A,Boyd Kimball D. Oxidative stress,amyloid-β peptide,and altered key molecular pathways in the pathogenesis and progression of alzheimer's disease[J]. J Alzheimers Dis,2018,62(3):1345-1367. doi: 10.3233/JAD-170543
    [24] Tamagno E,Guglielmotto M,Monteleone D,et al. The unexpected role of Aβ1-42 monomers in the pathogenesis of alzheimer's disease[J]. J Alzheimers Dis,2018,62(3):1241-1245. doi: 10.3233/JAD-170581
    [25] 黄攀,徐敏,何晓英,等. 阿尔茨海默病患者外周血microRNA-146a、Aβ_(1-42)蛋白、tau蛋白的表达及临床意义[J]. 中国免疫学杂志,2020,36(7):859-863.
    [26] Zeng Y Q,Cui Y B,Gu J H,et al. Scutellarin mitigates Aβ-Induced neurotoxicity and improves behavior impairments in AD mice[J]. Molecules,2018,23(4):869. doi: 10.3390/molecules23040869
    [27] 陈兴泳,张旭,汪银洲,等. 灯盏生脉胶囊口服结合运动训练对肾性高血压大鼠脑低密度脂蛋白相关受体蛋白-1、高度聚糖化作用终产物受体和β淀粉样蛋白1-42表达的影响[J]. 中国康复医学杂志,2016,31(3):247-262.
    [28] Guo L L,Guan Z Z,Huang Y,et al. The neurotoxicity of β-amyloid peptide toward rat brain is associated with enhanced oxidative stress,inflammation and apoptosis,all of which can be attenuated by scutellarin[J]. Exp Toxicol Pathol,2013,65(5):579-584. doi: 10.1016/j.etp.2012.05.003
    [29] Zhao Y,Qian Y,Sun Z,et al. Role of PI3K in the progression and regression of atherosclerosis[J]. Front Pharmacol,2021,12(3):632378.
    [30] 华宝桐,赵玲,蔡红雁,等. HCMEC细胞在灯盏花乙素及低能量震波联合作用下血管生成相关因子的研究[J]. 辽宁中医杂志,2016,43(10):2155-2157.
    [31] Mo J,Yang R,Li F,et al. Scutellarin protects against vascular endothelial dysfunction and prevents atherosclerosis via antioxidation[J]. Phytomedicine,2018,42(2):66-74.
    [32] Tousoulis D,Psaltopoulou T,Androulakis E,et al. Oxidative stress and early atherosclerosis:Novel antioxidant treatment[J]. Cardiovasc Drugs Ther,2015,29(1):75-88. doi: 10.1007/s10557-014-6562-5
    [33] 张小超,沈志强,杨仁华,等. 灯盏乙素对大鼠动脉粥样硬化的防治作用[J]. 中药药理与临床,2017,33(2):59-63.
    [34] Fu Y,Sun S,Sun H,et al. Scutellarin exerts protective effects against atherosclerosis in rats by regulating the hippo-FOXO3A and PI3K/AKT signaling pathways[J]. J Cell Physiol,2019,234(10):18131-18145. doi: 10.1002/jcp.28446
    [35] 林莉莉. 灯盏乙素和灯盏花素对心脑缺血性疾病的保护作用[D]. 上海: 第二军医大学硕士学位论文, 2007.
    [36] Huang H,Geng Q,Yao H,et al. Protective effect of scutellarin on myocardial infarction induced by isoprenaline in rats[J]. Iran J Basic Med Sci,2018,21(3):267-276.
    [37] Pan Z,Zhao W,Zhang X,et al. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2[J]. Br J Pharmacol,2011,162(3):688-700. doi: 10.1111/j.1476-5381.2010.01070.x
    [38] Wang Z,Yu J,Wu J,et al. Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress[J]. Life Sci,2016,157(7):200-207.
    [39] 季宇彬,马晓玉,陈荣昌,等. 灯盏乙素对心肌缺血/再灌注损伤的保护作用及机制[J]. 中国药理学通报,2019,35(5):648-653.
    [40] Zhu B H,Ma L,Pan X D,et al. Scutellarin induced Ca(2+ ) release and blocked KCl-induced Ca(2+ ) influx in smooth muscle cells isolated from rat thoracic artery[J]. J Asian Nat Prod Res,2008,10(5-6):583-589.
    [41] Pan Z W,Zhang Y,Mei D H,et al. Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways[J]. Naunyn Schmiedebergs Arch Pharmacol,2010,381(2):137-145. doi: 10.1007/s00210-009-0484-y
    [42] Manzanero S,Santro T,Arumugam T V. Neuronal oxidative stress in acute ischemic stroke:Sources and contribution to cell injury[J]. Neurochem Int,2013,62(5):712-718. doi: 10.1016/j.neuint.2012.11.009
    [43] Guo H,Hu L M,Wang S X,et al. Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity[J]. Chin J Physiol,2011,54(6):399-405.
    [44] 李岩. 灯盏花乙素调控NOX2治疗脑缺血再灌注损伤的作用机制研究[D]. 广州: 广州中医药大学博士学位论文, 2017.
    [45] Sun J B,Li Y,Cai Y F,et al. Scutellarin protects oxygen/glucose-deprived astrocytes and reduces focal cerebral ischemic injury[J]. Neural Regen Res,2018,13(8):1396-1407. doi: 10.4103/1673-5374.235293
    [46] Wu C Y,Fang M,Karthikeyan A,et al. Scutellarin attenuates microglia-mediated neuroinflammation and promotes astrogliosis in cerebral ischemia - A therapeutic consideration[J]. Curr Med Chem,2017,24(7):718-727. doi: 10.2174/0929867324666161118142045
    [47] Fang M,Yuan Y,Lu J,et al. Scutellarin promotes microglia-mediated astrogliosis coupled with improved behavioral function in cerebral ischemia[J]. Neurochem Int,2016,97(7):154-171.
    [48] Yuan Y,Rangarajan P,Kan E M,et al. Scutellarin regulates the notch pathway and affects the migration and morphological transformation of activated microglia in experimentally induced cerebral ischemia in rats and in activated BV-2 microglia[J]. J Neuroinflammation,2015,12(1):11. doi: 10.1186/s12974-014-0226-z
    [49] Chen H L,Jia W J,Li H E,et al. Scutellarin exerts anti-inflammatory effects in activated microglia/brain macrophage in cerebral ischemia and in activated BV-2 microglia through regulation of MAPKs signaling pathway[J]. Neuromolecular Med,2020,22(2):264-277. doi: 10.1007/s12017-019-08582-2
    [50] 朱君荣,李云曼,方伟蓉. 灯盏乙素对PC12细胞拟缺血性损伤的保护作用研究[J]. 中国药房,2009,20(15):1132-1135.
    [51] 刘畅. 灯盏花乙素对脑缺血神经元的保护作用及机制研究[D]. 昆明: 昆明医科大学硕士学位论文, 2019.
  • [1] 李威, 蒋立虹, 马丽晶, 陈锐, 杨童硕.  铁死亡在心肌病中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240327
    [2] 谭莹, 秦海燕, 孙翔, 苏彦伊, 王英宝.  丙泊酚调节MPP+诱导的SH-SY5Y细胞线粒体氧化应激和凋亡, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240305
    [3] 陆凤华, 杜兆霖, 章容.  红光照射联合下肢肌力训练对糖尿病周围神经病变患者下肢运动功能、TCSS评分及SOD水平的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230129
    [4] 白文娅, 杨渊, 霍思颖, 杨鑫, 邵建林.  胆绿素治疗作用的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220601
    [5] 薛国强, 卫欣欣, 姚娜, 赵文化.  二甲双胍通过调控PARP-1活性对2型糖尿病肾脏的保护作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210632
    [6] 郭安利, 付昌碧, 杨晓晴, 张士梅, 石正娟.  急性脑梗死患者肺部感染对氧化应激与炎性应激的影响, 昆明医科大学学报.
    [7] 曾庆菊, 李慧, 王晋文.  褪黑素对糖尿病大鼠氧化应激及足细胞凋亡的影响及作用机制, 昆明医科大学学报.
    [8] 戴青里, 孙贵虎, 闫斌, 郭涛, 戴青原.  过氧化氢诱导HUVECs氧化应激模型的构建, 昆明医科大学学报.
    [9] 陈晨, 王友兰, 刘伟军, 饶嫱, 杜庭彦, 杜晓华, 杨为民, 朱秀芬.  灯盏花乙素对人心脏微血管内皮细胞中PKCε表达的调控作用, 昆明医科大学学报.
    [10] 曾柏瑞.  甲基苯丙胺与HIV-Tat蛋白协同改变大鼠血脑屏障通透性的氧化应激作用机制, 昆明医科大学学报.
    [11] 边海霞.  单纯疱疹病毒性角膜炎抗氧化治疗的临床观察, 昆明医科大学学报.
    [12] 刘松.  1 800 MHz电磁波对大鼠心肌氧化应激的影响, 昆明医科大学学报.
    [13] 丁艳杰.  类风湿合并颈动脉硬化患者血清氧化应激状态与MMPs相关性分析, 昆明医科大学学报.
    [14] 胡娜.  灯盏花乙素和双嘧达莫舒张离体大鼠心脑血管的药理作用, 昆明医科大学学报.
    [15] 张媛.  1 800 MHz电磁辐射对大鼠皮肤组织氧化应激的影响, 昆明医科大学学报.
    [16] 李若楠.  三七总皂苷调控c-Jun氨基末端激酶改善大鼠肝组织胰岛素抵抗的作用, 昆明医科大学学报.
    [17] 王心昕.  膳食脂肪酸摄入及构成与心脑血管疾病相关性的研究进展, 昆明医科大学学报.
    [18] 闫庆峰.  木犀草素对冷保存大鼠心脏心功能及氧化应激反应的影响, 昆明医科大学学报.
    [19] 灯花乙素和灯盏花乙素苷元表观油水分配系数的测定与比较, 昆明医科大学学报.
    [20] 桂莉.  2型糖尿病大鼠骨骼肌氧化应激与胰岛素抵抗的关系, 昆明医科大学学报.
  • 加载中
计量
  • 文章访问数:  2993
  • HTML全文浏览量:  1891
  • PDF下载量:  24
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-02-14
  • 网络出版日期:  2022-03-23
  • 刊出日期:  2022-04-25

目录

    /

    返回文章
    返回